Regeneron Covid-19 Therapy Reduces Viral Load, Need for Care

(Bloomberg) -- Regeneron Pharmaceuticals Inc. said data from a late-stage clinical trial suggest that its antibody cocktail therapy for Covid-19 significantly reduces virus levels and the need for ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.